Overview

A Proof-of-concept Study to Examine QUC398 in Participants With Knee OA

Status:
Not yet recruiting
Trial end date:
2024-09-02
Target enrollment:
Participant gender:
Summary
The purpose of the study is to find out if the investigational treatment named QUC398 has beneficial effects on osteoarthritis knee pain and knee cartilage, and if it is safe and well tolerated.
Phase:
Phase 2
Details
Lead Sponsor:
Novartis Pharmaceuticals